Content
Frontiers of Medicine >> 2022, Volume 16, Issue 1 doi: 10.1007/s11684-021-0835-8
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
Abstract
Keywords
B-cell acute lymphoblastic leukemia ; bispecific antibody ; trispecific antibody ; CD19 ; CD20
Content